DS
IMUC

David Shaw’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

David Shaw’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,156
Closed -$148K – 4549
2014
Q3 		$148K Buy
4,156
+349
+9% +$13.4K ﹤0.01% 3944
2014
Q2 		$171K Buy
3,807
+352
+10% +$17K ﹤0.01% 4023
2014
Q1 		$169K Buy
3,455
+434
+14% +$21.2K ﹤0.01% 4114
2013
Q4 		$112K Buy
+3,021
New +$286K ﹤0.01% 4361
2013
Q3 		– Sell
-5,037
Closed -$391K – 4659
2013
Q2 		$391K Buy
+5,037
New +$482K ﹤0.01% 3417

Other funds holding IMUC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Callan Capital La Jolla, California $1.35B AUM 8.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

David Shaw's IMUC Position: Q4 2014 in Review

David Shaw sold out of ImmunoCellular Therapeutics, Ltd. (IMUC) in Q4 2014, closing a stake of 4,156 shares — an estimated $148K sold.

David Shaw first reported a position in IMUC in Q2 2013 and held it in 5 quarters. The position peaked at $391K in Q2 2013. 31 funds tracked by Wall St. Rank hold IMUC as of Q4 2014.

  • David Shaw reported no remaining ImmunoCellular Therapeutics, Ltd. position as of Q4 2014 after selling out during the quarter.
  • David Shaw sold 4,156 ImmunoCellular Therapeutics, Ltd. shares in Q4 2014, an estimated $148K.
  • David Shaw first reported a position in ImmunoCellular Therapeutics, Ltd. in Q2 2013 and held it in 5 quarters.
  • David Shaw's ImmunoCellular Therapeutics, Ltd. position peaked at $391K in Q2 2013.
  • 31 funds tracked by Wall St. Rank held ImmunoCellular Therapeutics, Ltd. as of Q4 2014.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.